Shilpa Medicare gets nod from European Authorities for Pemetrexed Injection
Shilpa Medicare’s Pemetrexed Injection 1000 mg/100 ml, 500 mg/50 ml & 100 mg/10 ml, Ready to use formulation is approved by European Authorities, through its agreed partners in Europe. The product will be manufactured, for EU commercialization at its own EU GMP compliant, injectable manufacturing facility situated in Telangana state. Shilpa has developed Pemetrexed formulation … Read more